Posttransplant outcomes for cPRA-100% recipients under the new Kidney Allocation System.
There is concern in the transplant community that outcomes for the most highly sensitized recipients might be poor under KAS high-prioritization. To study this, we compared posttransplant outcomes of 525 pre-KAS (12/4/2009-12/3/2014) cPRA-100% recipients to 3026 post-KAS (12/4/2014-12/3/2017) cPRA-100% recipients using SRTR data. We compared mortality and death-censored graft survival using Cox regression, acute rejection and delayed graft function (DGF) using logistic regression, and length of stay (LOS) using negative binomial regression. Compared to pre-KAS recipients, post-KAS recipients were allocated kidneys with lower KDPI (median 30% vs. 35%, p<0.001) but longer cold ischemic time (median 21.0 hours vs. 18.6, p<0.001). Compared to pre-KAS cPRA-100% recipients, those post-KAS had higher 3-year patient survival (93.6% vs. 91.4%, p=0.04) and 3-year death-censored graft survival (93.7% vs. 90.6%, p=0.005). The incidence of DGF (29.3%vs. 29.2%, p=0.9), acute rejection (11.2% vs. 11.7%, p=0.8), and median LOS (5 days vs. 5, p=0.2) were similar between pre-KAS and post-KAS recipients. After accounting for secular trends and adjusting for recipient characteristics, post-KAS recipients had no difference in mortality (adjusted hazard ratio [aHR]: 0.861.623.06, p=0.1), death-censored graft failure (aHR: 0.521.001.91, p>0.9), DGF (adjusted odds ratio [aOR]: 0.580.861.27, p=0.4), acute rejection (aOR: 0.610.941.43, p=0.8), and LOS (adjusted LOS ratio: 0.981.161.36, p=0.08). We did not find any statistically significant worsening of outcomes for cPRA-100% recipients under KAS, although longer-term monitoring of posttransplant mortality is warranted.